160 related articles for article (PubMed ID: 38438726)
21. Effect of hypertension on anticoagulated patients with atrial fibrillation.
Lip GY; Frison L; Grind M;
Eur Heart J; 2007 Mar; 28(6):752-9. PubMed ID: 17289744
[TBL] [Abstract][Full Text] [Related]
22. Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.
Lee SR; Choi EK; Han KD; Jung JH; Oh S; Lip GYH
J Am Coll Cardiol; 2018 Aug; 72(8):838-853. PubMed ID: 30115222
[TBL] [Abstract][Full Text] [Related]
23. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
24. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
25. Association of Visit-to-Visit Variability of Systolic Blood Pressure With Cardiovascular Disease and Mortality in Primary Care Chinese Patients With Type 2 Diabetes-A Retrospective Population-Based Cohort Study.
Wan EY; Fung CS; Yu EY; Fong DY; Chen JY; Lam CL
Diabetes Care; 2017 Feb; 40(2):270-279. PubMed ID: 27899498
[TBL] [Abstract][Full Text] [Related]
26. Visit-to-visit SBP variability and risk of atrial fibrillation in middle-aged and older populations.
Wang C; Sun Y; Xin Q; Han X; Cai Z; Zhao M; Yun C; Zhang S; Hou Z; Chen S; Wu S; Xue H
J Hypertens; 2022 Dec; 40(12):2521-2527. PubMed ID: 36214547
[TBL] [Abstract][Full Text] [Related]
27. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
28. Impact of Blood Pressure Visit-to-Visit Variability on Adverse Events in Patients With Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Inoue H; Atarashi H; Okumura K; Yamashita T; Otsuka T; Origasa H;
J Am Heart Assoc; 2021 Jan; 10(1):e018585. PubMed ID: 33372541
[TBL] [Abstract][Full Text] [Related]
29. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry.
Shiozawa M; Koga M; Inoue H; Yamashita T; Yasaka M; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Nakahara J; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T; Toyoda K
Int J Stroke; 2023 Oct; 18(8):986-995. PubMed ID: 37154598
[TBL] [Abstract][Full Text] [Related]
30. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Harrington J; Carnicelli AP; Hua K; Wallentin L; Patel MR; Hohnloser SH; Giugliano RP; Fox KAA; Hijazi Z; Lopes RD; Pokorney SD; Hong H; Granger CB
Circulation; 2023 Jun; 147(23):1748-1757. PubMed ID: 37042255
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
Chao TF; Chen SA; Ruff CT; Hamershock RA; Mercuri MF; Antman EM; Braunwald E; Giugliano RP
Eur Heart J; 2019 May; 40(19):1518-1527. PubMed ID: 30590425
[TBL] [Abstract][Full Text] [Related]
32. Non-vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years.
Tsai CT; Liao JN; Chen SJ; Jiang YR; Chen TJ; Chao TF
Eur J Clin Invest; 2021 Jun; 51(6):e13488. PubMed ID: 33420738
[TBL] [Abstract][Full Text] [Related]
33. Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.
Lim TW; Camm AJ; Virdone S; Singer DE; Bassand JP; Fonarow GC; Fox KAA; Ezekowitz M; Gersh BJ; Kayani G; Hylek EM; Kakkar AK; Mahaffey KW; Pieper KS; Peterson ED; Piccini JP;
Clin Cardiol; 2023 Nov; 46(11):1398-1407. PubMed ID: 37596725
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation.
Okumura K; Tomita H; Nakai M; Kodani E; Akao M; Suzuki S; Hayashi K; Sawano M; Goya M; Yamashita T; Fukuda K; Ogawa H; Tsuda T; Isobe M; Toyoda K; Miyamoto Y; Miyata H; Okamura T; Sasahara Y;
JAMA Netw Open; 2020 Apr; 3(4):e202881. PubMed ID: 32293685
[TBL] [Abstract][Full Text] [Related]
35. Visit-to-visit variability in systolic blood pressure is a novel risk factor for the growth of intracranial aneurysms.
Igase M; Igase K; Kohara K; Yamashita S; Fujisawa M; Katagi R; Miki T
Cerebrovasc Dis; 2013; 36(5-6):401-6. PubMed ID: 24246968
[TBL] [Abstract][Full Text] [Related]
36. Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
Krittayaphong R; Winijkul A; Kunjara-Na-Ayudhya R; Apiyasawat S; Siriwattana K; Kanjanarutjawiwat W; Dutsadeevettakul S; Lip GYH;
Stroke; 2020 Jun; 51(6):1772-1780. PubMed ID: 32390554
[TBL] [Abstract][Full Text] [Related]
37. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.
Hankey GJ; Stevens SR; Piccini JP; Lokhnygina Y; Mahaffey KW; Halperin JL; Patel MR; Breithardt G; Singer DE; Becker RC; Berkowitz SD; Paolini JF; Nessel CC; Hacke W; Fox KA; Califf RM;
Stroke; 2014 May; 45(5):1304-12. PubMed ID: 24743444
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure visit-to-visit variability and outcomes in patients with heart failure with preserved ejection fraction.
Zhang Q; Zhou B; Ma Y; Hu Y; Li X; Cong H
ESC Heart Fail; 2021 Oct; 8(5):3984-3996. PubMed ID: 34405581
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
Cha MJ; Choi EK; Han KD; Lee SR; Lim WH; Oh S; Lip GYH
Stroke; 2017 Nov; 48(11):3040-3048. PubMed ID: 28974629
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]